SCM
Sterling Capital Management Portfolio holdings
AUM
$7.04B
1-Year Return
20.28%
This Quarter Return
+7.37%
1 Year Return
+20.28%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$7.74B
AUM Growth
–
Cap. Flow
+$7.74B
Cap. Flow
% of AUM
100%
Top 10 Holdings %
Top 10 Hldgs %
23.39%
Holding
3,274
New
3,268
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Microsoft
MSFT
|
+$330M |
| 2 |
UnitedHealth
UNH
|
+$213M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$179M |
| 4 |
Hershey
HSY
|
+$168M |
| 5 |
Automatic Data Processing
ADP
|
+$158M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Technology | 22.83% |
| 2 | Financials | 18.4% |
| 3 | Healthcare | 14.22% |
| 4 | Consumer Discretionary | 9.6% |
| 5 | Industrials | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1776
iShares ESG Aware US Aggregate Bond ETF
EAGG
$4.15B
| $4.03K | ﹤0.01% |
+83
| New | +$4.03K |
|
1777
Shake Shack
SHAK
$4.06B
| $4.03K | ﹤0.01% |
+39
| New | +$4.03K |
|
1778
Haemonetics
HAE
$2.51B
| $4.02K | ﹤0.01% |
+50
| New | +$4.02K |
|
1779
Advanced Energy
AEIS
$5.94B
| $4K | ﹤0.01% |
+38
| New | +$4K |
|
1780
Cactus
WHD
$2.74B
| $4K | ﹤0.01% |
+67
| New | +$4K |
|
|
UMH
1781
UMH Properties
UMH
$1.29B
| $3.99K | ﹤0.01% |
+203
| New | +$3.99K |
|
1782
Diebold Nixdorf
DBD
$2.17B
| $3.93K | ﹤0.01% |
+88
| New | +$3.93K |
|
1783
Weis Markets
WMK
$1.75B
| $3.93K | ﹤0.01% |
+57
| New | +$3.93K |
|
1784
Cars.com
CARS
$829M
| $3.87K | ﹤0.01% |
+231
| New | +$3.87K |
|
1785
Cavco Industries
CVCO
$4.32B
| $3.85K | ﹤0.01% |
+9
| New | +$3.85K |
|
1786
SFL Corp
SFL
$1.06B
| $3.85K | ﹤0.01% |
+333
| New | +$3.85K |
|
1787
Sensient Technologies
SXT
$4.52B
| $3.85K | ﹤0.01% |
+48
| New | +$3.85K |
|
1788
Biohaven
BHVN
$1.47B
| $3.85K | ﹤0.01% |
+77
| New | +$3.85K |
|
1789
Avanos Medical
AVNS
$567M
| $3.85K | ﹤0.01% |
+160
| New | +$3.85K |
|
1790
Innospec
IOSP
$2.05B
| $3.85K | ﹤0.01% |
+34
| New | +$3.85K |
|
1791
Corcept Therapeutics
CORT
$7.68B
| $3.84K | ﹤0.01% |
+83
| New | +$3.84K |
|
1792
Calix
CALX
$4.01B
| $3.84K | ﹤0.01% |
+99
| New | +$3.84K |
|
1793
German American Bancorp
GABC
$1.53B
| $3.84K | ﹤0.01% |
+99
| New | +$3.84K |
|
1794
Encore Capital Group
ECPG
$1.02B
| $3.83K | ﹤0.01% |
+81
| New | +$3.83K |
|
1795
Winmark
WINA
$1.74B
| $3.83K | ﹤0.01% |
+10
| New | +$3.83K |
|
1796
Madrigal Pharmaceuticals
MDGL
$9.63B
| $3.82K | ﹤0.01% |
+18
| New | +$3.82K |
|
1797
Acadia Pharmaceuticals
ACAD
$3.98B
| $3.81K | ﹤0.01% |
+248
| New | +$3.81K |
|
1798
John Wiley & Sons Class A
WLY
$2.19B
| $3.81K | ﹤0.01% |
+79
| New | +$3.81K |
|
1799
RXO
RXO
$2.71B
| $3.81K | ﹤0.01% |
+136
| New | +$3.81K |
|
1800
Ingles Markets
IMKTA
$1.32B
| $3.81K | ﹤0.01% |
+51
| New | +$3.81K |
|